On June 25, 2026, UpDoc Inc., a clinical AI company, announced that it received clearance from FDA for what the company describes as the first Software as a Medical Device (SaMD) that uses patient-facing large language models (LLMs). UpDoc describes its platform as an enterprise-ready agentic clinical AI platform designed to enable clinicians to deploy
Latest Post
More Posts
FDA and EMA Provide Guiding Principles for AI in Drug Development
HHS Proposed Rule May Enhance HIPAA Security but Leaves AI Questions Open
Consumer Product and Retail Brown-Bag Lunch Series: Cannabis News
Ounce of Prevention: Do You Have Business Associate Agreements With Every Required Party?
Ounce of Prevention: Is It Time to Perform a Security Risk Assessment?
Illinois Jumps on the Food Ingredient ‘Banned’ Wagon
1st Circuit Rejects Convicted Former Medical Device Executives’ Off-Label “Free Speech” Theory
FDA Warning Letter Declares Delta-8 and CBD Gummies ‘Adulterated Foods’
Homeland Security and HHS Release Interactive Healthcare Cybersecurity Toolkit
Subscribe: Subscribe via RSS